Abstract
Additional research on public and private demand for HIV vaccines is needed to strengthen ongoing advocacy and planning for eventual vaccine introduction, say Hecht and Suraratdecha.
MeSH terms
-
AIDS Vaccines / economics
-
AIDS Vaccines / supply & distribution*
-
Developing Countries / economics
-
Global Health*
-
HIV Infections / economics
-
HIV Infections / prevention & control*
-
Health Care Costs
-
Health Policy*
-
Health Services Needs and Demand*
-
Humans
-
International Cooperation
-
Patient Acceptance of Health Care
-
Private Sector / economics
-
Public Sector / economics